Electroconvulsive Therapy Devices: FDA Proposes 510(k), Special Controls
This article was originally published in The Gray Sheet
FDA is proposing to reclassify electroconvulsive therapy devices aimed at treating major depressive disorder to class II with special controls, but require PMAs for other indications. The proposal does not align with a 2011 FDA panel recommendation to keep ECTs for depression in the class III category and require PMAs.
Register for our free email digests: